Egypt vs Sri Lanka: Death rate from cancer
Egypt
82.54 deaths per 100,000 people
in 2021
Sri Lanka
79.7 deaths per 100,000 people
in 2021
Egypt rank
107th
Sri Lanka rank
109th
Death rate from cancer over time
- Egypt
- Sri Lanka
How they compare
Egypt currently reports 82.54 deaths per 100,000 people against 79.7 deaths per 100,000 people in Sri Lanka, a difference of 2.84 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Sri Lanka ahead.
Egypt ranks 107th and Sri Lanka ranks 109th of 194 countries.
Across the 3 decades both report, Egypt averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Egypt | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.12 deaths per 100,000 people | 83.32 deaths per 100,000 people | 9.19 deaths per 100,000 people | Sri Lanka |
| 2010s | 80.88 deaths per 100,000 people | 85.97 deaths per 100,000 people | 5.09 deaths per 100,000 people | Sri Lanka |
| 2020s | 81.38 deaths per 100,000 people | 72.86 deaths per 100,000 people | 8.52 deaths per 100,000 people | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Egypt or Sri Lanka?
- Egypt, at 82.54 deaths per 100,000 people against 79.7 deaths per 100,000 people in Sri Lanka as of 2021.
- What is the difference in death rate from cancer between Egypt and Sri Lanka?
- 2.84 deaths per 100,000 people, with Egypt ahead.
- How many years of comparable data are there for Egypt and Sri Lanka?
- 22 years are reported by both, from 2000 to 2021.
- How do Egypt and Sri Lanka rank globally for death rate from cancer?
- Egypt ranks 107th and Sri Lanka ranks 109th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.